Safety of CHIR-258 (TKI258) in Advanced Solid Tumors
NCT01270906 · Status: TERMINATED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 35
Last updated 2011-01-05
Summary
Phase I dose finding study in solid tumors.
Conditions
Interventions
- DRUG
-
CHIR-258 (TKI258)
Sponsors & Collaborators
-
Chiron Corporation
collaborator INDUSTRY - lead INDUSTRY
Principal Investigators
-
Novartis Pharmaceuticals · Novartis Pharmaceuticals
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2003-12-31
- Primary Completion
- 2006-10-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
Study of Safety and Efficacy of DKY709 Alone or in Combination With PDR001 in Patients With Advanced Solid Tumors.
NCT03891953 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Safety and Tolerability of SHR-1316 in Subjects With Advanced Tumors
NCT03474289 ·Status: UNKNOWN ·Phase: PHASE1
-
Safety, Tolerability and Pharmacokinetics of the New Formulation SHR-1316 in Subjects With Advanced Tumors
NCT04979390 ·Status: UNKNOWN ·Phase: PHASE1
-
A Study to Evaluate the Tolerance and Pharmacokinetics of TQB2858 Injection in Subjects With Terminal Malignant Tumors
NCT04805060 ·Status: RECRUITING ·Phase: PHASE1
-
Study of INC280 in Patients With c-MET Dependent Advanced Solid Tumors
NCT01324479 ·Status: COMPLETED ·Phase: PHASE1
-
A Research Study of JNJ-26854165 to Determine the Safety and Dose in Patients With Advanced Stage or Refractory Solid Tumors.
NCT00676910 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase I Study of Safety, Tolerability, and PK of AZD2811 in Patients With Advanced Solid Tumors.
NCT02579226 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Trial of TQB3015 Tablets in Patients With Advanced Malignant Cancer
NCT06165809 ·Status: WITHDRAWN ·Phase: PHASE1
-
A Dose-escalation Study in Subjects With Advanced Malignancies
NCT01072266 ·Status: COMPLETED ·Phase: PHASE1
-
A Study Exploring the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB086550 in Participants With Advanced Solid Tumors
NCT03762447 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of HS-20122 in Patients With Advanced Solid Tumors
NCT06927570 ·Status: RECRUITING ·Phase: PHASE1
-
A Dose Escalation Study of the Safety and Pharmacokinetics of GSK1363089 (Formerly XL880) Administered Orally Daily to Subjects With Solid Tumors
NCT00743067 ·Status: COMPLETED ·Phase: PHASE1
-
A Safety and Dose-finding Study of JNJ-26483327, a Drug in Development for Cancer, for Patients With Advanced and/or Refractory Solid Malignancies.
NCT00676299 ·Status: COMPLETED ·Phase: PHASE1
-
A Trial to Evaluate Safety and Tolerability of INCSHR01210 in Cancer Patients
NCT02492789 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of KK2269 in Adult Participants With Solid Tumors
NCT06266299 ·Status: RECRUITING ·Phase: PHASE1
-
A Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of TT125-802 in Subjects With Advanced Solid Tumors
NCT06403436 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
PTC596 in Patients With Advanced Solid Tumors
NCT02404480 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of DS-1103a Combination Therapy in Participants With Advanced Solid Tumors
NCT05765851 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Safety Study of X-82 in Patients With Advanced Solid Tumors
NCT01296581 ·Status: COMPLETED ·Phase: PHASE1
-
A Study Evaluating the Safety of Escalating Doses of DLYE5953A in Patients With Refractory Solid Tumors
NCT02092792 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Pharmacokinetics and Preliminary Efficacy of CS231295 in Advanced Solid Tumors
NCT06902350 ·Status: RECRUITING ·Phase: PHASE1
-
A Study Evaluating the Safety and Tolerability of GDC-0068 in Patients With Refractory Solid Tumors
NCT01090960 ·Status: COMPLETED ·Phase: PHASE1
-
Study of ONO-7579 in Patients With Advanced Solid Tumors/ NTRK Gene Fusion Positive Advanced Solid Tumors
NCT03182257 ·Status: TERMINATED ·Phase: PHASE1
-
SJG-136 in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery
NCT00121290 ·Status: COMPLETED ·Phase: PHASE1
-
Subjects With Advanced or Metastatic Solid Tumor Malignancies
NCT05474859 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1